3.0T-MRI表观扩散系数预测肺腺癌脑转移全脑放疗联合化疗疗效
3.0T-MRI Mean Apparent Diffusion Coefficient May Predict Tumor Response to Whole-Brain Radiation Therapy Combined with Chemotherapy in Lung Adenocarcinoma Patients with Brain Metastases
摘要: 目的：探讨表观扩散系数(ADC)对肺腺癌多发脑转移全脑放疗联合全身化疗疗效的预测作用。方法：选取青岛大学附属医院2019年7月~2023年7月收治的60例肺腺癌合并多发脑转移行WBRT联合化疗的患者，于治疗前、治疗开始后12周内行磁共振弥散加权成像检查测定ADC值。依据实体瘤的疗效评价标准(RECIST)评价疗效，讨论治疗前MRI扩散加权成像表观扩散系数(pre-ADCmean)、δADC值与放化疗疗效之间的关系。结果：60例患者中同步放化疗治疗有效者32例，无效者28例。治疗有效组pre-ADCmean高于治疗无效组(P < 0.05)。ROC分析结果显示，pre-ADCmean值预测肺腺癌多发脑转移患者同步放化疗疗效的曲线下面积(AUC) > 0.70，有一定预测价值。结论：3.0T-MRI扩散加权成像表观扩散系数可预测肺腺癌多发脑转移行全脑放疗联合化疗疗效。
Abstract: Objective: The objective was to evaluate the performance of ADC as a predictor of treatment outcomes associated with WBRT and chemotherapeutic agents in patients affected by lung adenocarcinoma (LUAD) originating in brain metastases (BMs). Methods: A retrospective analysis was conducted of 60 patients with LUAD with BMs who underwent WBRT and chemotherapy at the Affiliated Hospital of Qingdao University from July 2019 to July 2023, and measured the ADC value by DWI imaging before and within 12 weeks after treatment. According to the response evaluation criteria in solid tumors (RECIST), the efficacy was evaluated, and the relationships between pre-ADCmean and δADC values on MRI diffusion-weighted imaging and the efficacy of radiotherapy and chemotherapy were discussed. Results: Among the 60 patients, there were 32 responded to chemoradiotherapy, while 28 did not. The pre-ADCmean values of the effective group was higher than that of the ineffective group (P < 0.05). The ROC analysis showed that the pre-ADCmean value had a predictive value for the efficacy of concurrent chemoradiotherapy in patients with multiple brain metastases from lung adenocarcinoma, with an area under the curve (AUC) of >0.70. Conclusion: The apparent diffusion coefficient of 3.0T-MRI diffusion-weighted imaging can predict the efficacy of whole brain radiotherapy combined with chemotherapy for multiple brain metastases from lung adenocarcinoma.
文章引用：王秋晓, 任瑞美. 3.0T-MRI表观扩散系数预测肺腺癌脑转移全脑放疗联合化疗疗效[J]. 临床医学进展, 2025, 15(1): 264-273. https://doi.org/10.12677/acm.2025.151038

参考文献

[1] Lah, T.T., Novak, M. and Breznik, B. (2020) Brain Malignancies: Glioblastoma and Brain Metastases. Seminars in Cancer Biology, 60, 262-273. [Google Scholar] [CrossRef] [PubMed]
[2] Li, Y., Liu, Y., Liang, Y., Wei, R., Zhang, W., Yao, W., et al. (2022) Radiomics Can Differentiate High-Grade Glioma from Brain Metastasis: A Systematic Review and Meta-analysis. European Radiology, 32, 8039-8051. [Google Scholar] [CrossRef] [PubMed]
[3] Takei, H., Rouah, E. and Ishida, Y. (2015) Brain Metastasis: Clinical Characteristics, Pathological Findings and Molecular Subtyping for Therapeutic Implications. Brain Tumor Pathology, 33, 1-12. [Google Scholar] [CrossRef] [PubMed]
[4] Lapointe, S., Perry, A. and Butowski, N.A. (2018) Primary Brain Tumours in Adults. The Lancet, 392, 432-446. [Google Scholar] [CrossRef] [PubMed]
[5] Cagney, D.N., Martin, A.M., Catalano, P.J., Redig, A.J., Lin, N.U., Lee, E.Q., et al. (2017) Incidence and Prognosis of Patients with Brain Metastases at Diagnosis of Systemic Malignancy: A Population-Based Study. Neuro-Oncology, 19, 1511-1521. [Google Scholar] [CrossRef] [PubMed]
[6] Kuksis, M., Gao, Y., Tran, W., Hoey, C., Kiss, A., Komorowski, A.S., et al. (2020) The Incidence of Brain Metastases among Patients with Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. Neuro-Oncology, 23, 894-904. [Google Scholar] [CrossRef] [PubMed]
[7] Passiglia, F., Caglevic, C., Giovannetti, E., Pinto, J., Manca, P., Taverna, S., et al. (2018) Primary and Metastatic Brain Cancer Genomics and Emerging Biomarkers for Immunomodulatory Cancer Treatment. Seminars in Cancer Biology, 52, 259-268. [Google Scholar] [CrossRef] [PubMed]
[8] Boire, A., Brastianos, P.K., Garzia, L. and Valiente, M. (2019) Brain Metastasis. Nature Reviews Cancer, 20, 4-11. [Google Scholar] [CrossRef] [PubMed]
[9] Arvanitis, C.D., Ferraro, G.B. and Jain, R.K. (2019) The Blood-Brain Barrier and Blood-Tumour Barrier in Brain Tumours and Metastases. Nature Reviews Cancer, 20, 26-41. [Google Scholar] [CrossRef] [PubMed]
[10] Suh, J.H., Kotecha, R., Chao, S.T., Ahluwalia, M.S., Sahgal, A. and Chang, E.L. (2020) Current Approaches to the Management of Brain Metastases. Nature Reviews Clinical Oncology, 17, 279-299. [Google Scholar] [CrossRef] [PubMed]
[11] Page, S., Milner-Watts, C., Perna, M., Janzic, U., Vidal, N., Kaudeer, N., et al. (2020) Systemic Treatment of Brain Metastases in Non-Small Cell Lung Cancer. European Journal of Cancer, 132, 187-198. [Google Scholar] [CrossRef] [PubMed]
[12] Messina, C., Bignone, R., Bruno, A., Bruno, A., Bruno, F., Calandri, M., et al. (2020) Diffusion-Weighted Imaging in Oncology: An Update. Cancers, 12, Article 1493. [Google Scholar] [CrossRef] [PubMed]
[13] Sobeh, T., Inbar, Y., Apter, S., Soffer, S., Anteby, R., Kraus, M., et al. (2023) Diffusion-Weighted MRI for Predicting and Assessing Treatment Response of Liver Metastases from CRC—A Systematic Review and Meta-Analysis. European Journal of Radiology, 163, Article ID: 110810. [Google Scholar] [CrossRef] [PubMed]
[14] Bozdağ, M., Er, A. and Çinkooğlu, A. (2020) Histogram Analysis of ADC Maps for Differentiating Brain Metastases from Different Histological Types of Lung Cancers. Canadian Association of Radiologists Journal, 72, 271-278. [Google Scholar] [CrossRef] [PubMed]
[15] Müller, S.J., Khadhraoui, E., Neef, N.E., Riedel, C.H. and Ernst, M. (2021) Differentiation of Brain Metastases from Small and Non-Small Lung Cancers Using Apparent Diffusion Coefficient (ADC) Maps. BMC Medical Imaging, 21, Article No. 70. [Google Scholar] [CrossRef] [PubMed]
[16] Nieder, C., Andratschke, N.H. and Grosu, A.L. (2023) Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy? Seminars in Radiation Oncology, 33, 129-138. [Google Scholar] [CrossRef] [PubMed]
[17] Smits, M. (2021) MRI Biomarkers in Neuro-Oncology. Nature Reviews Neurology, 17, 486-500. [Google Scholar] [CrossRef] [PubMed]
[18] Borggreve, A.S., Heethuis, S.E., Boekhoff, M.R., Goense, L., van Rossum, P.S.N., Brosens, L.A.A., et al. (2019) Optimal Timing for Prediction of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy with Diffusion-Weighted MRI in Patients with Esophageal Cancer. European Radiology, 30, 1896-1907. [Google Scholar] [CrossRef] [PubMed]
[19] Zhao, L., Zhao, M., Liu, J., Yang, H., Zhou, X., Wen, C., et al. (2021) Mean Apparent Diffusion Coefficient in a Single Slice May Predict Tumor Response to Whole-Brain Radiation Therapy in Non-Small-Cell Lung Cancer Patients with Brain Metastases. European Radiology, 31, 5565-5575. [Google Scholar] [CrossRef] [PubMed]
[20] Jung, W.S., Park, C.H., Hong, C., Suh, S.H. and Ahn, S.J. (2018) Diffusion-Weighted Imaging of Brain Metastasis from Lung Cancer: Correlation of MRI Parameters with the Histologic Type and Gene Mutation Status. American Journal of Neuroradiology, 39, 273-279. [Google Scholar] [CrossRef] [PubMed]
[21] Jakubovic, R., Zhou, S., Heyn, C., Soliman, H., Zhang, L., Aviv, R., et al. (2016) The Predictive Capacity of Apparent Diffusion Coefficient (ADC) in Response Assessment of Brain Metastases Following Radiation. Clinical & Experimental Metastasis, 33, 277-284. [Google Scholar] [CrossRef] [PubMed]
[22] Jiang, C., Liu, X., Qu, Q., Jiang, Z. and Wang, Y. (2023) Prediction of Adenocarcinoma and Squamous Carcinoma Based on CT Perfusion Parameters of Brain Metastases from Lung Cancer: A Pilot Study. Frontiers in Oncology, 13, Article 1225170. [Google Scholar] [CrossRef] [PubMed]
[23] Razek, A.A.K.A., Tawfik, A.M., Elsorogy, L.G.A. and Soliman, N.Y. (2014) Perfusion CT of Head and Neck Cancer. European Journal of Radiology, 83, 537-544. [Google Scholar] [CrossRef] [PubMed]
[24] Brynolfsson, P., Lerner, M., Sundgren, P.C., Jamtheim Gustafsson, C., Nilsson, M., Szczepankiewicz, F., et al. (2022) Tensor-Valued Diffusion Magnetic Resonance Imaging in a Radiotherapy Setting. Physics and Imaging in Radiation Oncology, 24, 144-151. [Google Scholar] [CrossRef] [PubMed]
[25] Henderson, F., Abdullah, K.G., Verma, R. and Brem, S. (2020) Tractography and the Connectome in Neurosurgical Treatment of Gliomas: The Premise, the Progress, and the Potential. Neurosurgical Focus, 48, E6. [Google Scholar] [CrossRef] [PubMed]
[26] Lindner, T., Bolar, D.S., Achten, E., Barkhof, F., Bastos‐Leite, A.J., Detre, J.A., et al. (2023) Current State and Guidance on Arterial Spin Labeling Perfusion MRI in Clinical Neuroimaging. Magnetic Resonance in Medicine, 89, 2024-2047. [Google Scholar] [CrossRef] [PubMed]
[27] Manning, P., Daghighi, S., Rajaratnam, M.K., Parthiban, S., Bahrami, N., Dale, A.M., et al. (2020) Differentiation of Progressive Disease from Pseudoprogression Using 3D PCASL and DSC Perfusion MRI in Patients with Glioblastoma. Journal of Neuro-Oncology, 147, 681-690. [Google Scholar] [CrossRef] [PubMed]

为你推荐